35.71
Precedente Chiudi:
$35.86
Aprire:
$36.14
Volume 24 ore:
17,461
Relative Volume:
0.47
Capitalizzazione di mercato:
$218.37M
Reddito:
-
Utile/perdita netta:
$-7.12M
Rapporto P/E:
-15.53
EPS:
-2.3
Flusso di cassa netto:
$-6.82M
1 W Prestazione:
+3.06%
1M Prestazione:
-10.19%
6M Prestazione:
-17.15%
1 anno Prestazione:
+1,407%
Monopar Therapeutics Inc Stock (MNPR) Company Profile
Nome
Monopar Therapeutics Inc
Settore
Industria
Telefono
(847) 388-0349
Indirizzo
1000 SKOKIE BLVD SUITE 350, WILMETTE
Confronta MNPR con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MNPR
Monopar Therapeutics Inc
|
35.71 | 219.29M | 0 | -7.12M | -6.82M | -2.30 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
2025-06-23 | Iniziato | Chardan Capital Markets | Buy |
2025-03-19 | Ripresa | Piper Sandler | Overweight |
2025-01-10 | Iniziato | Piper Sandler | Overweight |
2024-10-11 | Iniziato | Rodman & Renshaw | Buy |
2021-01-28 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Monopar Therapeutics Inc Borsa (MNPR) Ultime notizie
MNPR FY2025 EPS Increased by Brookline Capital Management - Defense World
How to use a screener to detect Monopar Therapeutics Inc. breakoutsJuly 2025 Action & Long-Term Growth Stock Strategies - Newser
Using Bollinger Bands to evaluate Monopar Therapeutics Inc.2025 Trading Recap & AI Enhanced Trading Signals - Newser
Chart based exit strategy for Monopar Therapeutics Inc.Portfolio Performance Report & Low Drawdown Momentum Trade Ideas - Newser
Can swing trading help recover from Monopar Therapeutics Inc. lossesMarket Rally & AI Enhanced Execution Alerts - Newser
Will Volume Confirm Reversal in Monopar Therapeutics Inc.Quarterly Growth Report & Real-Time Chart Breakout Alerts - newsyoung.net
Traders Consider Averaging Down in Monopar Therapeutics Inc.July 2025 Short Interest & Verified Chart Pattern Signals - metal.it
Monopar Therapeutics Inc. stock trend forecastPortfolio Performance Report & AI Forecasted Entry/Exit Points - Newser
Is it too late to sell Monopar Therapeutics Inc.July 2025 PostEarnings & Community Verified Trade Signals - Newser
Is Monopar Therapeutics Inc. stock reversal real or fakeBond Market & Stepwise Entry/Exit Trade Alerts - Newser
Does Monopar Therapeutics Inc. fit your quant trading model2025 Winners & Losers & Fast Entry High Yield Tips - Newser
Published on: 2025-08-15 22:52:10 - Newser
Applying Elliott Wave Theory to Monopar Therapeutics Inc.July 2025 Fed Impact & Advanced Technical Signal Analysis - Newser
How to escape a deep drawdown in Monopar Therapeutics Inc.Day Trade & Capital Efficiency Focused Strategies - Newser
What the charts say about Monopar Therapeutics Inc. todayJuly 2025 Weekly Recap & Capital Efficiency Focused Strategies - Newser
Will Monopar Therapeutics Inc. price bounce be sustainableJuly 2025 Highlights & Verified Entry Point Signals - Newser
How to monitor Monopar Therapeutics Inc. with trend dashboards2025 Winners & Losers & Technical Pattern Based Buy Signals - Newser
Does Monopar Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Final Week & Technical Pattern Recognition Alerts - Newser
Monopar Therapeutics (NASDAQ:MNPR) Earns “Buy” Rating from Chardan Capital - Defense World
Is Monopar Therapeutics Inc. stock showing strong momentum2025 Investor Takeaways & Real-Time Buy Zone Alerts - thegnnews.com
Monopar Therapeutics Inc. Attempts Reversal From Key Support2025 Sector Review & Free High Return Stock Watch Alerts - thegnnews.com
What makes Monopar Therapeutics Inc. stock price move sharply2025 Biggest Moves & AI Powered Buy/Sell Recommendations - Newser
Combining price and volume data for Monopar Therapeutics Inc.2025 Sector Review & Growth Oriented Trade Recommendations - Newser
When is the best time to buy Monopar Therapeutics Inc. stockM&A Rumor & Daily Stock Trend Reports - Newser
Monopar Therapeutics Inc. stock volume spike explained2025 Geopolitical Influence & Weekly Breakout Watchlists - Newser
Will Monopar Therapeutics Inc. outperform the market2025 Trade Ideas & Safe Entry Momentum Stock Tips - Newser
Monopar Therapeutics Reports Increased R&D Expenses - TipRanks
Monopar Therapeutics Inc. Breaks Losing Streak — Is the Trend ReversingTop Gaining Picks With Entry Signals Identified - 선데이타임즈
Monopar Therapeutics Inc. Reports Q2 2025 Financial Results and Progress on ALXN1840 and MNPR-101 Clinical Trials - Quiver Quantitative
Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments - The Manila Times
Monopar Therapeutics SEC 10-Q Report - TradingView
Monopar Q2 Earnings: $53.3M Cash Position Funds Wilson Disease Drug NDA | MNPR Stock News - Stock Titan
Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Will Monopar Therapeutics Inc. stock go up soonAI Pattern Recognition and Trade Prediction - Newser
Monopar Therapeutics Inc. stock trendline breakdownRisk Managed Watchlist with Breakout Picks - Newser
How Monopar Therapeutics Inc. stock performs during market volatilityStock Price Prediction Using AI Tools - Newser
Monopar Therapeutics Inc Azioni (MNPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):